Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
AVAILABLE
NCT01916148

18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia

Sponsor: Children's Hospital of Philadelphia

View on ClinicalTrials.gov

Summary

This purpose of this study is to determine the ability of an 18F-fluoro-L-dihydroxyphenylalanine (18F-DOPA) PET (Positron Emission Tomography) scan to detect a focal lesion of hyperinsulinism and determine the location in patients with congenital hyperinsulinism, Beckwith Wiedemann Syndrome and suspected insulinoma. Safety data will be collected.

Official title: Expanded Access Use of 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia

Key Details

Gender

All

Age Range

Any - Any

Study Type

EXPANDED_ACCESS

Enrollment

Not specified

Start Date

Not specified

Completion Date

Not specified

Last Updated

2026-04-27

Healthy Volunteers

Not specified

Interventions

DRUG

18F-DOPA

18F-DOPA is a PET (Positron Emission Tomography) scan radiotracer.

Locations (1)

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States